Recursion Pharmaceuticals Inc

Companies

For Recursion Pharmaceuticals Inc [RXRX], Analyst sees a rise to $5. What next?

Edison Baldwin

Recursion Pharmaceuticals Inc [NASDAQ: RXRX] loss -0.54% on the last trading session, reaching $5.49 price per share at the time. ...

Market

why Recursion Pharmaceuticals Inc [RXRX] is a Good Choice for Investors After New Price Target of $6.47

Annabelle Farmer

Recursion Pharmaceuticals Inc [NASDAQ: RXRX] jumped around 0.09 points on Friday, while shares priced at $4.72 at the close of ...

Industry

Recursion Pharmaceuticals Inc [RXRX] stock Resumed by Morgan Stanley analyst, price target now $5

Edison Baldwin

Recursion Pharmaceuticals Inc [NASDAQ: RXRX] closed the trading session at $4.91 on 2025-09-19. The day’s price range saw the stock ...

Companies

Recursion Pharmaceuticals Inc [RXRX] fell -23.58% so far this year. What now?

Annabelle Farmer

Recursion Pharmaceuticals Inc [NASDAQ: RXRX] stock went on a downward path that fall over -0.41% on Friday, amounting to a ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.